Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

universal biosensors

  • Home
  •  
  • universal biosensors



  • Most Read
  • Latest Comments
  • Universal Biosensors receives FDA approval for its blood coagulation device
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Universal Biosensors receives FDA approval for its blood coagulation device
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Universal Biosensors receives FDA approval for its blood coagulation device
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Universal Biosensors receives FDA approval for its blood coagulation device
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Universal Biosensors receives FDA approval for its blood coagulation device
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    PainChek locks in performance data for FDA submission, aiming to be first pain assessment app approved in US
    • News

  • HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    • News

  • dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    • News

  • Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    • News

  • TGA approves Control Bionic’s autonomous wheelchair for commercial sales after NDIS delays
    TGA approves Control Bionic’s autonomous wheelchair for commercial sales after NDIS delays
    • News

  • Universal Biosensors receives FDA approval for its blood coagulation device
    • News

    Universal Biosensors receives FDA approval for its blood coagulation device

    Aussie biosensor company Universal Biosensors (ASX: UBI) has received the US FDA 510(k) and CLIA Waiver approval for its Xprecia Prime Coagulation Analyzer as a Class II device. Xprecia Prime is a portable coagulation monitoring device that provides fast and accurate PT/INR testing (measuring how long it takes for blood to clot) specifically for patients

    Read More
    Public
  • Universal Biosensors secures five more distributors for its Petrackr diabetes monitor
    • News

    Universal Biosensors secures five more distributors for its Petrackr diabetes monitor

    Bolstering its market presence and catering for growing demand from pet health conscious owners, Universal Biosensors (ASX: UBI) has secured partnerships with five new distribution partners for its Petrackr product. Petrackr is a biosensor tech product developed by Universal Biosensors, designed to monitor and track the level of blood glucose in real-time. These biomarkers hold

    Read More
    Public
  • Universal Biosensors launches diabetes monitoring device for cats and dogs in the US
    • News

    Universal Biosensors launches diabetes monitoring device for cats and dogs in the US

    In the land of sugar and fat, health concerns for the general population are rising and this has extended towards our furry friends where diabetes in cats and dogs are a real risk which is being addressed by biotech company Universal Biosensors (ASX: UBI) and their blood sugar monitoring device.  As the latest extension of

    Read More
    Public
  • Universal Biosensors partners with Peter Mac for handheld cancer diagnosis device
    • News

    Universal Biosensors partners with Peter Mac for handheld cancer diagnosis device

    A handheld device which can remotely diagnose the presence of cancer cells is on the horizon with biotech company Universal Biosensors (ASX: UBI) partnering with the Peter MacCallum Cancer Centre on the project.  Under the agreement, Peter Mac will supply cancer patient samples to Universal Biosensors which will use the plasma samples in their trials

    Read More
    Public
  • Universal Biosensors enters collaboration to diagnose cancer from a finger prick
    • News

    Universal Biosensors enters collaboration to diagnose cancer from a finger prick

    Life expectancy rates following the diagnosis of cancer could soon be significantly improved through early detection if biotech company Universal Biosensors (ASX: UBI) is successful in their newest research collaboration aiming to instantly identify cancer cells from a simple finger prick.  The research project will be part of an exclusive collaboration between Deakin University’s Institute

    Read More
    Public
  • Universal Biosensors brings winetech device to US to boost quality of wine
    • News

    Universal Biosensors brings winetech device to US to boost quality of wine

    The art of winemaking is getting ever more scientific and this will be accelerated in the United States with Universal Biosensors (ASX: UBI) hand-held element tester to commence distribution through the American wine industry. The Sentia™ Analyzer is a handheld device that enables winemakers to test various levels of acidity and sugars in their wine

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.